Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency

X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management.

Gespeichert in:

Autor*in:	Yang, Linlin [verfasserIn] Booth, Claire Speckmann, Carsten Seidel, Markus G. Worth, Austen J.J. Kindle, Gerhard Lankester, Arjan C. Grimbacher, Bodo Sediva, Anna Neven, Benedicte Hauck, Fabian Warnatz, Klaus Pac, Malgorzata Carrabba, Maria Palacin, Pere Jandus, Peter Gardulf, Ann Mahlaoui, Nizar Pergent, Martine Schutz, Catharina Sharapova, Svetlana Vassilios, Lougaris Candotti, Fabio Volpi, Stephano

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2022

Schlagwörter:	phenotype conservative treatment HLH therapy primary immunodeficiency IBD adult survival outcomes HSCT X-linked inhibitor of apoptosis XIAP deficiency

Umfang:	11

Übergeordnetes Werk:	Enthalten in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward - Papakitsou, I. ELSEVIER, 2022, official publication of the American Academy of Allergy, Asthma and Immunology, Amsterdam [u.a.]
Übergeordnetes Werk:	volume:150 ; year:2022 ; number:2 ; pages:456-466 ; extent:11

Links:	Volltext

DOI / URN:	10.1016/j.jaci.2021.10.037

Katalog-ID:	ELV058520775

Internformat


LEADER	01000caa a22002652 4500
001	ELV058520775
003	DE-627
005	20230625005700.0
007	cr uuu---uuuuu
008	221103s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.jaci.2021.10.037 \|2 doi
028	5	2	\|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica
035			\|a (DE-627)ELV058520775
035			\|a (ELSEVIER)S0091-6749(21)02597-5
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a 44.85 \|2 bkl
100	1		\|a Yang, Linlin \|e verfasserin \|4 aut
245	1	0	\|a Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
264		1	\|c 2022
300			\|a 11
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
520			\|a X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management.
650		7	\|a phenotype \|2 Elsevier
650		7	\|a conservative treatment \|2 Elsevier
650		7	\|a HLH \|2 Elsevier
650		7	\|a therapy \|2 Elsevier
650		7	\|a primary immunodeficiency \|2 Elsevier
650		7	\|a IBD \|2 Elsevier
650		7	\|a adult \|2 Elsevier
650		7	\|a survival outcomes \|2 Elsevier
650		7	\|a HSCT \|2 Elsevier
650		7	\|a X-linked inhibitor of apoptosis \|2 Elsevier
650		7	\|a XIAP deficiency \|2 Elsevier
700	1		\|a Booth, Claire \|4 oth
700	1		\|a Speckmann, Carsten \|4 oth
700	1		\|a Seidel, Markus G. \|4 oth
700	1		\|a Worth, Austen J.J. \|4 oth
700	1		\|a Kindle, Gerhard \|4 oth
700	1		\|a Lankester, Arjan C. \|4 oth
700	1		\|a Grimbacher, Bodo \|4 oth
700	1		\|a Sediva, Anna \|4 oth
700	1		\|a Neven, Benedicte \|4 oth
700	1		\|a Hauck, Fabian \|4 oth
700	1		\|a Warnatz, Klaus \|4 oth
700	1		\|a Pac, Malgorzata \|4 oth
700	1		\|a Carrabba, Maria \|4 oth
700	1		\|a Palacin, Pere \|4 oth
700	1		\|a Jandus, Peter \|4 oth
700	1		\|a Gardulf, Ann \|4 oth
700	1		\|a Mahlaoui, Nizar \|4 oth
700	1		\|a Pergent, Martine \|4 oth
700	1		\|a Schutz, Catharina \|4 oth
700	1		\|a Sharapova, Svetlana \|4 oth
700	1		\|a Vassilios, Lougaris \|4 oth
700	1		\|a Candotti, Fabio \|4 oth
700	1		\|a Volpi, Stephano \|4 oth
773	0	8	\|i Enthalten in \|n Elsevier \|a Papakitsou, I. ELSEVIER \|t Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward \|d 2022 \|d official publication of the American Academy of Allergy, Asthma and Immunology \|g Amsterdam [u.a.] \|w (DE-627)ELV000021164
773	1	8	\|g volume:150 \|g year:2022 \|g number:2 \|g pages:456-466 \|g extent:11
856	4	0	\|u https://doi.org/10.1016/j.jaci.2021.10.037 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a SSG-OLC-PHA
936	b	k	\|a 44.85 \|j Kardiologie \|j Angiologie \|q VZ
951			\|a AR
952			\|d 150 \|j 2022 \|e 2 \|h 456-466 \|g 11

Indexfelder

author_variant	l y ly
matchkey_str	yanglinlinboothclairespeckmanncarstensei:2022----:hntpgntptetetnsriaotoeiptetwtxikdnii
hierarchy_sort_str	2022
bklnumber	44.85
publishDate	2022
allfields	10.1016/j.jaci.2021.10.037 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica (DE-627)ELV058520775 (ELSEVIER)S0091-6749(21)02597-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Yang, Linlin verfasserin aut Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency 2022 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management. phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency Elsevier Booth, Claire oth Speckmann, Carsten oth Seidel, Markus G. oth Worth, Austen J.J. oth Kindle, Gerhard oth Lankester, Arjan C. oth Grimbacher, Bodo oth Sediva, Anna oth Neven, Benedicte oth Hauck, Fabian oth Warnatz, Klaus oth Pac, Malgorzata oth Carrabba, Maria oth Palacin, Pere oth Jandus, Peter oth Gardulf, Ann oth Mahlaoui, Nizar oth Pergent, Martine oth Schutz, Catharina oth Sharapova, Svetlana oth Vassilios, Lougaris oth Candotti, Fabio oth Volpi, Stephano oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:150 year:2022 number:2 pages:456-466 extent:11 https://doi.org/10.1016/j.jaci.2021.10.037 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 150 2022 2 456-466 11
spelling	10.1016/j.jaci.2021.10.037 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica (DE-627)ELV058520775 (ELSEVIER)S0091-6749(21)02597-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Yang, Linlin verfasserin aut Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency 2022 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management. phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency Elsevier Booth, Claire oth Speckmann, Carsten oth Seidel, Markus G. oth Worth, Austen J.J. oth Kindle, Gerhard oth Lankester, Arjan C. oth Grimbacher, Bodo oth Sediva, Anna oth Neven, Benedicte oth Hauck, Fabian oth Warnatz, Klaus oth Pac, Malgorzata oth Carrabba, Maria oth Palacin, Pere oth Jandus, Peter oth Gardulf, Ann oth Mahlaoui, Nizar oth Pergent, Martine oth Schutz, Catharina oth Sharapova, Svetlana oth Vassilios, Lougaris oth Candotti, Fabio oth Volpi, Stephano oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:150 year:2022 number:2 pages:456-466 extent:11 https://doi.org/10.1016/j.jaci.2021.10.037 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 150 2022 2 456-466 11
allfields_unstemmed	10.1016/j.jaci.2021.10.037 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica (DE-627)ELV058520775 (ELSEVIER)S0091-6749(21)02597-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Yang, Linlin verfasserin aut Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency 2022 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management. phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency Elsevier Booth, Claire oth Speckmann, Carsten oth Seidel, Markus G. oth Worth, Austen J.J. oth Kindle, Gerhard oth Lankester, Arjan C. oth Grimbacher, Bodo oth Sediva, Anna oth Neven, Benedicte oth Hauck, Fabian oth Warnatz, Klaus oth Pac, Malgorzata oth Carrabba, Maria oth Palacin, Pere oth Jandus, Peter oth Gardulf, Ann oth Mahlaoui, Nizar oth Pergent, Martine oth Schutz, Catharina oth Sharapova, Svetlana oth Vassilios, Lougaris oth Candotti, Fabio oth Volpi, Stephano oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:150 year:2022 number:2 pages:456-466 extent:11 https://doi.org/10.1016/j.jaci.2021.10.037 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 150 2022 2 456-466 11
allfieldsGer	10.1016/j.jaci.2021.10.037 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica (DE-627)ELV058520775 (ELSEVIER)S0091-6749(21)02597-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Yang, Linlin verfasserin aut Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency 2022 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management. phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency Elsevier Booth, Claire oth Speckmann, Carsten oth Seidel, Markus G. oth Worth, Austen J.J. oth Kindle, Gerhard oth Lankester, Arjan C. oth Grimbacher, Bodo oth Sediva, Anna oth Neven, Benedicte oth Hauck, Fabian oth Warnatz, Klaus oth Pac, Malgorzata oth Carrabba, Maria oth Palacin, Pere oth Jandus, Peter oth Gardulf, Ann oth Mahlaoui, Nizar oth Pergent, Martine oth Schutz, Catharina oth Sharapova, Svetlana oth Vassilios, Lougaris oth Candotti, Fabio oth Volpi, Stephano oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:150 year:2022 number:2 pages:456-466 extent:11 https://doi.org/10.1016/j.jaci.2021.10.037 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 150 2022 2 456-466 11
allfieldsSound	10.1016/j.jaci.2021.10.037 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica (DE-627)ELV058520775 (ELSEVIER)S0091-6749(21)02597-5 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Yang, Linlin verfasserin aut Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency 2022 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management. phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency Elsevier Booth, Claire oth Speckmann, Carsten oth Seidel, Markus G. oth Worth, Austen J.J. oth Kindle, Gerhard oth Lankester, Arjan C. oth Grimbacher, Bodo oth Sediva, Anna oth Neven, Benedicte oth Hauck, Fabian oth Warnatz, Klaus oth Pac, Malgorzata oth Carrabba, Maria oth Palacin, Pere oth Jandus, Peter oth Gardulf, Ann oth Mahlaoui, Nizar oth Pergent, Martine oth Schutz, Catharina oth Sharapova, Svetlana oth Vassilios, Lougaris oth Candotti, Fabio oth Volpi, Stephano oth Enthalten in Elsevier Papakitsou, I. ELSEVIER Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward 2022 official publication of the American Academy of Allergy, Asthma and Immunology Amsterdam [u.a.] (DE-627)ELV000021164 volume:150 year:2022 number:2 pages:456-466 extent:11 https://doi.org/10.1016/j.jaci.2021.10.037 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 150 2022 2 456-466 11
language	English
source	Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:150 year:2022 number:2 pages:456-466 extent:11
sourceStr	Enthalten in Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward Amsterdam [u.a.] volume:150 year:2022 number:2 pages:456-466 extent:11
format_phy_str_mv	Article
bklname	Kardiologie Angiologie
institution	findex.gbv.de
topic_facet	phenotype conservative treatment HLH therapy primary immunodeficiency IBD adult survival outcomes HSCT X-linked inhibitor of apoptosis XIAP deficiency
dewey-raw	610
isfreeaccess_bool	false
container_title	Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward
authorswithroles_txt_mv	Yang, Linlin @@aut@@ Booth, Claire @@oth@@ Speckmann, Carsten @@oth@@ Seidel, Markus G. @@oth@@ Worth, Austen J.J. @@oth@@ Kindle, Gerhard @@oth@@ Lankester, Arjan C. @@oth@@ Grimbacher, Bodo @@oth@@ Sediva, Anna @@oth@@ Neven, Benedicte @@oth@@ Hauck, Fabian @@oth@@ Warnatz, Klaus @@oth@@ Pac, Malgorzata @@oth@@ Carrabba, Maria @@oth@@ Palacin, Pere @@oth@@ Jandus, Peter @@oth@@ Gardulf, Ann @@oth@@ Mahlaoui, Nizar @@oth@@ Pergent, Martine @@oth@@ Schutz, Catharina @@oth@@ Sharapova, Svetlana @@oth@@ Vassilios, Lougaris @@oth@@ Candotti, Fabio @@oth@@ Volpi, Stephano @@oth@@
publishDateDaySort_date	2022-01-01T00:00:00Z
hierarchy_top_id	ELV000021164
dewey-sort	3610
id	ELV058520775
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058520775</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625005700.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221103s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2021.10.037</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058520775</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(21)02597-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yang, Linlin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">phenotype</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">conservative treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HLH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">primary immunodeficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IBD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">adult</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">survival outcomes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">X-linked inhibitor of apoptosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">XIAP deficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Booth, Claire</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Speckmann, Carsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seidel, Markus G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Worth, Austen J.J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kindle, Gerhard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lankester, Arjan C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grimbacher, Bodo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sediva, Anna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neven, Benedicte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hauck, Fabian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Warnatz, Klaus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pac, Malgorzata</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrabba, Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Palacin, Pere</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jandus, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gardulf, Ann</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahlaoui, Nizar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pergent, Martine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schutz, Catharina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharapova, Svetlana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vassilios, Lougaris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Candotti, Fabio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Volpi, Stephano</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:150</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:456-466</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2021.10.037</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">150</subfield><subfield code="j">2022</subfield><subfield code="e">2</subfield><subfield code="h">456-466</subfield><subfield code="g">11</subfield></datafield></record></collection>
author	Yang, Linlin
spellingShingle	Yang, Linlin ddc 610 bkl 44.85 Elsevier phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
authorStr	Yang, Linlin
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV000021164
format	electronic Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 VZ 44.85 bkl Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency Elsevier
topic	ddc 610 bkl 44.85 Elsevier phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency
topic_unstemmed	ddc 610 bkl 44.85 Elsevier phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency
topic_browse	ddc 610 bkl 44.85 Elsevier phenotype Elsevier conservative treatment Elsevier HLH Elsevier therapy Elsevier primary immunodeficiency Elsevier IBD Elsevier adult Elsevier survival outcomes Elsevier HSCT Elsevier X-linked inhibitor of apoptosis Elsevier XIAP deficiency
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	c b cb c s cs m g s mg mgs a j w aj ajw g k gk a c l ac acl b g bg a s as b n bn f h fh k w kw m p mp m c mc p p pp p j pj a g ag n m nm m p mp c s cs s s ss l v lv f c fc s v sv
hierarchy_parent_title	Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward
hierarchy_parent_id	ELV000021164
dewey-tens	610 - Medicine & health
hierarchy_top_title	Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV000021164
title	Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
ctrlnum	(DE-627)ELV058520775 (ELSEVIER)S0091-6749(21)02597-5
title_full	Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
author_sort	Yang, Linlin
journal	Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward
journalStr	Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2022
contenttype_str_mv	zzz
container_start_page	456
author_browse	Yang, Linlin
container_volume	150
physical	11
class	610 VZ 44.85 bkl
format_se	Elektronische Aufsätze
author-letter	Yang, Linlin
doi_str_mv	10.1016/j.jaci.2021.10.037
dewey-full	610
title_sort	phenotype, genotype, treatment, and survival outcomes in patients with x-linked inhibitor of apoptosis deficiency
title_auth	Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
abstract	X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management.
abstractGer	X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management.
abstract_unstemmed	X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management.
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA
container_issue	2
title_short	Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency
url	https://doi.org/10.1016/j.jaci.2021.10.037
remote_bool	true
author2	Booth, Claire Speckmann, Carsten Seidel, Markus G. Worth, Austen J.J. Kindle, Gerhard Lankester, Arjan C. Grimbacher, Bodo Sediva, Anna Neven, Benedicte Hauck, Fabian Warnatz, Klaus Pac, Malgorzata Carrabba, Maria Palacin, Pere Jandus, Peter Gardulf, Ann Mahlaoui, Nizar Pergent, Martine Schutz, Catharina Sharapova, Svetlana Vassilios, Lougaris Candotti, Fabio Volpi, Stephano
author2Str	Booth, Claire Speckmann, Carsten Seidel, Markus G. Worth, Austen J.J. Kindle, Gerhard Lankester, Arjan C. Grimbacher, Bodo Sediva, Anna Neven, Benedicte Hauck, Fabian Warnatz, Klaus Pac, Malgorzata Carrabba, Maria Palacin, Pere Jandus, Peter Gardulf, Ann Mahlaoui, Nizar Pergent, Martine Schutz, Catharina Sharapova, Svetlana Vassilios, Lougaris Candotti, Fabio Volpi, Stephano
ppnlink	ELV000021164
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth
doi_str	10.1016/j.jaci.2021.10.037
up_date	2024-07-06T19:16:00.956Z
_version_	1803858331258847232
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV058520775</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625005700.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221103s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jaci.2021.10.037</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001856.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV058520775</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0091-6749(21)02597-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yang, Linlin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency disease caused by XIAP gene mutations. A broad range of phenotype, severity, and age at onset present challenges for patient management.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">phenotype</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">conservative treatment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HLH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">therapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">primary immunodeficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IBD</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">adult</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">survival outcomes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HSCT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">X-linked inhibitor of apoptosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">XIAP deficiency</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Booth, Claire</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Speckmann, Carsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seidel, Markus G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Worth, Austen J.J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kindle, Gerhard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lankester, Arjan C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grimbacher, Bodo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sediva, Anna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neven, Benedicte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hauck, Fabian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Warnatz, Klaus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pac, Malgorzata</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carrabba, Maria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Palacin, Pere</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jandus, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gardulf, Ann</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahlaoui, Nizar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pergent, Martine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schutz, Catharina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharapova, Svetlana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vassilios, Lougaris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Candotti, Fabio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Volpi, Stephano</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Papakitsou, I. ELSEVIER</subfield><subfield code="t">Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward</subfield><subfield code="d">2022</subfield><subfield code="d">official publication of the American Academy of Allergy, Asthma and Immunology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000021164</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:150</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:456-466</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jaci.2021.10.037</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">150</subfield><subfield code="j">2022</subfield><subfield code="e">2</subfield><subfield code="h">456-466</subfield><subfield code="g">11</subfield></datafield></record></collection>
score	7.40007

Nicht das Richtige dabei?

Schreiben Sie uns!

Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?